Poseida Therapeutics, Inc. Shares Issued
Poseida Therapeutics, Inc. had Shares Issued of 97.41 million shares as of 2024-09-30, per its 10-Q filed 2024-11-07.
Financial Statements › Balance Sheet › Equity › Common Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:CommonStockSharesIssued · last filed 2024-11-07
- 2024-09-30: Common Stock, Shares, Issued 97.41M shares.
- 2024-06-30: Common Stock, Shares, Issued 97.08M shares.
- 2024-03-31: Common Stock, Shares, Issued 96.80M shares.
- 2023-12-31: Common Stock, Shares, Issued 95.64M shares.
| Period end | Common Stock, Shares, Issued |
|---|---|
| 2024-09-30 | 97.41M shares 10-Q · filed 2024-11-07 |
| 2024-06-30 | 97.08M shares 10-Q · filed 2024-08-05 |
| 2024-03-31 | 96.80M shares 10-Q · filed 2024-05-14 |
| 2023-12-31 | 95.64M shares 10-Q · filed 2024-11-07 |
| 2023-09-30 | 95.57M shares 10-Q · filed 2023-11-09 |
| 2023-06-30 | 86.88M shares 10-Q · filed 2023-08-08 |
| 2023-03-31 | 86.76M shares 10-Q · filed 2023-05-09 |
| 2022-12-31 | 85.96M shares 10-K · filed 2024-03-07 |
| 2022-09-30 | 85.95M shares 10-Q · filed 2022-11-10 |
| 2022-06-30 | 62.73M shares 10-Q · filed 2022-08-11 |
| 2022-03-31 | 62.70M shares 10-Q · filed 2022-05-12 |
| 2021-12-31 | 62.52M shares 10-K · filed 2023-03-09 |
| 2021-09-30 | 62.47M shares 10-Q · filed 2021-11-09 |
| 2021-06-30 | 62.17M shares 10-Q · filed 2021-08-12 |
| 2021-03-31 | 62.13M shares 10-Q · filed 2021-05-11 |
| 2020-12-31 | 61.86M shares 10-K · filed 2022-03-10 |
| 2020-09-30 | 61.82M shares 10-Q · filed 2020-11-12 |
| 2020-06-30 | 13.37M shares 10-Q · filed 2020-08-20 |
| 2019-12-31 | 13.20M shares 10-K · filed 2021-03-11 |